Patents by Inventor Tang-Long Shen

Tang-Long Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11103551
    Abstract: The present invention is related to a method or a pharmaceutical composition for treatment or prevention of a cancer through blocking the interaction of ?4 integrin and focal adhesion kinase (FAK).
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: August 31, 2021
    Inventors: Tang-Long Shen, Yu-Ling Tai, Hsin-Jung Wu
  • Publication number: 20180177845
    Abstract: The present invention is related to a method or a pharmaceutical composition for treatment or prevention of a cancer through blocking the interaction of ?4 integrin and focal adhesion kinase (FAK).
    Type: Application
    Filed: November 9, 2017
    Publication date: June 28, 2018
    Inventors: Tang-Long Shen, Yu-Ling Tai, Hsing-Jung WU
  • Patent number: 9809805
    Abstract: The present invention relates to a new zinc binding fusion protein that is a fusion protein of glutathione S-transferase (GST) and metallothionein (MT), to which zinc bind, providing an efficacy in preventing or treating a ROS-related disease and heavy metal poisoning.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: November 7, 2017
    Assignee: ACRO BIOTECH CO., LTD.
    Inventors: Chiao-Wei Lin, Tang-Long Shen, Ko-Chien Chen, Jer-Li Lin, Sheng-Hong Tsai